Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

638 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial.
Bonilha I, Gomes ÉIL, Carmo HRP, Breder I, Barreto J, Breder J, Munhoz DB, Carvalho LSF, Quinaglia T, Kimura-Medorima ST, Gossi CM, Zimetti F, Nadruz W, Zanotti I, Sposito AC; EXCEED-BHS3 Group. Bonilha I, et al. Among authors: barreto j. Int J Mol Sci. 2024 Apr 8;25(7):4108. doi: 10.3390/ijms25074108. Int J Mol Sci. 2024. PMID: 38612917 Free PMC article.
Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial.
Sposito AC, Breder I, Barreto J, Breder J, Bonilha I, Lima M, Oliveira A, Wolf V, Luchiari B, do Carmo HR, Munhoz D, Oliveira D, Coelho-Filho OR, Coelho OR, Matos-Souza JR, Moura FA, de Carvalho LSF, Nadruz W, Quinaglia T, Kimura-Medorima ST; EXCEED-BHS3 Group. Sposito AC, et al. Among authors: barreto j. Cardiovasc Diabetol. 2022 Aug 6;21(1):147. doi: 10.1186/s12933-022-01584-8. Cardiovasc Diabetol. 2022. PMID: 35933413 Free PMC article. Clinical Trial.
HDL-Targeted Therapies During Myocardial Infarction.
Sposito AC, Carmo HR, Barreto J, Sun L, Carvalho LSF, Feinstein SB, Zanotti I, Kontush A, Remaley A. Sposito AC, et al. Among authors: barreto j. Cardiovasc Drugs Ther. 2019 Jun;33(3):371-381. doi: 10.1007/s10557-019-06865-1. Cardiovasc Drugs Ther. 2019. PMID: 30778806 Review.
Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial.
Sposito AC, Breder I, Soares AAS, Kimura-Medorima ST, Munhoz DB, Cintra RMR, Bonilha I, Oliveira DC, Breder JC, Cavalcante P, Moreira C, Moura FA, de Lima-Junior JC, do Carmo HRP, Barreto J, Nadruz W, Carvalho LSF, Quinaglia T; ADDENDA-BHS2 trial investigators. Sposito AC, et al. Among authors: barreto j. Cardiovasc Diabetol. 2021 Mar 26;20(1):74. doi: 10.1186/s12933-021-01264-z. Cardiovasc Diabetol. 2021. PMID: 33771149 Free PMC article. Clinical Trial.
Dapagliflozin increases the lean-to total mass ratio in type 2 diabetes mellitus.
Wolf VLW, Breder I, de Carvalho LSF, Soares AAS, Cintra RM, Barreto J, Munhoz DB, Kimura-Medorima ST, Nadruz W, Guerra-Júnior G, Quinaglia T, Muscelli E, Sposito AC; Addenda-BHS2 trial investigators. Wolf VLW, et al. Among authors: barreto j. Nutr Diabetes. 2021 Jun 12;11(1):17. doi: 10.1038/s41387-021-00160-5. Nutr Diabetes. 2021. PMID: 34120150 Free PMC article. Clinical Trial.
Compliance with Cardiovascular Prevention Guidelines in Type 2 Diabetes Individuals in a Middle-Income Region: A Cross-Sectional Analysis.
Barreto J, Luchiari B, Wolf VLW, Bonilha I, Bovi TG, Assato BS, Breder I, Kimura-Medorima ST, Munhoz DB, Quinaglia T, Coelho-Filho OR, Carvalho LSF, Nadruz W, Sposito AC. Barreto J, et al. Diagnostics (Basel). 2022 Mar 26;12(4):814. doi: 10.3390/diagnostics12040814. Diagnostics (Basel). 2022. PMID: 35453862 Free PMC article.
Carotid intima layer thickness but not intima-media thickness is related to coronary artery calcification in type 2 diabetes individuals: Results from the Brazilian diabetes study.
Martins NS, Barreto J, Kimura-Medorima ST, Vitte SH, Quinaglia T, Assato B, Coelho-Filho OR, Matos-Souza JR, Nadruz W, Sposito AC; Brazilian Heart Study Group. Martins NS, et al. Among authors: barreto j. Nutr Metab Cardiovasc Dis. 2023 Dec;33(12):2384-2388. doi: 10.1016/j.numecd.2023.07.033. Epub 2023 Aug 3. Nutr Metab Cardiovasc Dis. 2023. PMID: 37798228
Prevalence, treatment, and control of dyslipidemia in diabetic participants of two brazilian cohorts: a place far from heaven.
Martins NS, Mello DSS, Barreto J, Soares AAS, Breder I, Cunha J, Nadruz W, Coelho Filho OR, Matos-Souza JR, Coelho OR, Munhoz DB, Silva JCQE, Sposito AC, Carvalho LSF. Martins NS, et al. Among authors: barreto j. Rev Assoc Med Bras (1992). 2019 Jan;65(1):3-8. doi: 10.1590/1806-9282.65.1.3. Rev Assoc Med Bras (1992). 2019. PMID: 30758413 Free article.
Reciprocal Multifaceted Interaction Between HDL (High-Density Lipoprotein) and Myocardial Infarction.
Sposito AC, de Lima-Junior JC, Moura FA, Barreto J, Bonilha I, Santana M, Virginio VW, Sun L, Carvalho LSF, Soares AAS, Nadruz W, Feinstein SB, Nofer JR, Zanotti I, Kontush A, Remaley AT. Sposito AC, et al. Among authors: barreto j. Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1550-1564. doi: 10.1161/ATVBAHA.119.312880. Epub 2019 Jun 13. Arterioscler Thromb Vasc Biol. 2019. PMID: 31189429 Free article. Review.
638 results